Format
Sort by
Items per page

Send to

Choose Destination

Best matches for diabetes mellitus, non-insulin-dependent AND hypoglycemia AND treatment outcome:

Search results

Items: 1 to 20 of 1432

1.

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus.

Wu H, Liu J, Lou Q, Liu J, Shen L, Zhang M, Lv X, Gu M, Guo X.

Medicine (Baltimore). 2017 Sep;96(35):e7533. doi: 10.1097/MD.0000000000007533.

2.

Lean diabetes in middle-aged adults: A joint analysis of the German DIVE and DPV registries.

Hartmann B, Lanzinger S, Bramlage P, Groß F, Danne T, Wagner S, Krakow D, Zimmermann A, Malcharzik C, Holl RW.

PLoS One. 2017 Aug 21;12(8):e0183235. doi: 10.1371/journal.pone.0183235. eCollection 2017.

3.

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.

Areosa Sastre A, Vernooij RW, González-Colaço Harmand M, Martínez G.

Cochrane Database Syst Rev. 2017 Jun 15;6:CD003804. doi: 10.1002/14651858.CD003804.pub2. Review.

PMID:
28617932
4.

Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.

Thrasher J.

Am J Cardiol. 2017 Jul 1;120(1S):S4-S16. doi: 10.1016/j.amjcard.2017.05.009. Epub 2017 May 30. Review.

5.

Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.

Thrasher J.

Am J Med. 2017 Jun;130(6S):S4-S17. doi: 10.1016/j.amjmed.2017.04.004. Review.

6.

Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients.

Twigg G, Motsko J, Thomas J, David T.

Consult Pharm. 2017 May 1;32(5):299-310. doi: 10.4140/TCP.n.2017.299.

PMID:
28483010
7.

Lifestyle interventions for the treatment of women with gestational diabetes.

Brown J, Alwan NA, West J, Brown S, McKinlay CJ, Farrar D, Crowther CA.

Cochrane Database Syst Rev. 2017 May 4;5:CD011970. doi: 10.1002/14651858.CD011970.pub2. Review.

PMID:
28472859
9.

Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences.

von Arx LB, Johnson FR, Mørkbak MR, Kjær T.

Value Health. 2017 Apr;20(4):670-678. doi: 10.1016/j.jval.2016.11.023. Epub 2017 Feb 9.

PMID:
28408010
10.
11.

Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population.

Meng J, Casciano R, Lee YC, Stern L, Gultyaev D, Tong L, Kitio-Dschassi B.

J Manag Care Spec Pharm. 2017 Apr;23(4):446-452. doi: 10.18553/jmcp.2017.23.4.446.

12.

SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUO.

Lingvay I.

Endocr Pract. 2017 Jul;23(7):831-840. doi: 10.4158/EP161725.RA. Epub 2017 Mar 23. Review.

PMID:
28332871
13.

Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt - results from the GUARD study.

Shelbaya S, Rakha S.

Curr Med Res Opin. 2017 May;33(5):797-801. doi: 10.1080/03007995.2016.1277199. Epub 2017 Mar 17.

PMID:
28303721
14.

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Kay S, Strickson A, Puelles J, Selby R, Benson E, Tolley K.

Diabetes Ther. 2017 Apr;8(2):251-273. doi: 10.1007/s13300-017-0245-8. Epub 2017 Mar 8. Review.

15.

Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial.

Furler J, O'Neal D, Speight J, Manski-Nankervis JA, Gorelik A, Holmes-Truscott E, Ginnivan L, Young D, Best J; dean, Patterson E, Liew D, Segal L, May C, Blackberry I.

BMJ. 2017 Mar 8;356:j783. doi: 10.1136/bmj.j783.

16.

Dulaglutide for the treatment of type 2 diabetes.

Scheen AJ.

Expert Opin Biol Ther. 2017 Apr;17(4):485-496. doi: 10.1080/14712598.2017.1296131. Epub 2017 Feb 28. Review.

PMID:
28274140
17.

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S.

Cochrane Database Syst Rev. 2017 Feb 27;2:CD009966. doi: 10.1002/14651858.CD009966.pub2. Review.

PMID:
28238223
18.

PURLs: Need an add-on to metformin? Consider this.

Wyncott D, Lyon C, Mounsey A.

J Fam Pract. 2017 Jan;66(1):42-44. Review.

19.

Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin.

Saito D, Kanazawa A, Shigihara N, Sato F, Uchida T, Sato J, Goto H, Miyatsuka T, Ikeda F, Ogihara T, Ohmura C, Watada H.

J Clin Med Res. 2017 Mar;9(3):193-199. doi: 10.14740/jocmr2874w. Epub 2017 Jan 25.

20.

Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive systematic review of current options.

Raccah D.

Diabetes Metab. 2017 Apr;43(2):110-124. doi: 10.1016/j.diabet.2016.11.007. Epub 2017 Feb 4. Review.

PMID:
28169086

Supplemental Content

Loading ...
Support Center